Advertisement
Advertisement

CARL

CARL logo

Carlsmed, Inc. Common Stock

13.82
USD
Sponsored
+0.12
+0.88%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

14.01

+0.19
+1.35%

CARL Earnings Reports

Positive Surprise Ratio

CARL beat 4 of 4 last estimates.

100%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$19.32M
/
-$0.41
Implied change from Q2 26 (Revenue/ EPS)
+1.99%
/
+5.13%
Implied change from Q3 25 (Revenue/ EPS)
+47.75%
/
+2.50%

Carlsmed, Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, CARL reported earnings of -0.39 USD per share (EPS) for Q2 26, beating the estimate of -0.41 USD, resulting in a 6.30% surprise. Revenue reached 18.94 million, compared to an expected 18.31 million, with a 3.46% difference. The market reacted with a +1.03% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.41 USD, with revenue projected to reach 19.32 million USD, implying an increase of 5.13% EPS, and increase of 1.99% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Enovis Corporation
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.86
Actual
$0.90
Surprise
+3.97%
logo
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
logo
Evolent Health, Inc Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.02
Surprise
+183.68%
logo
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
logo
Health Catalyst, Inc Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.02
Actual
$0.04
Surprise
+45.45%
logo
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
logo
Outset Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.80
Surprise
-7.87%
logo
10x Genomics, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.14
Surprise
+43.09%
logo
iRhythm Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.57
Surprise
+12,988.89%
logo
Doximity, Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.31
Actual
$0.28
Surprise
-6.66%
FAQ
For Q2 2026, Carlsmed, Inc. Common Stock reported EPS of -$0.39, beating estimates by 6.3%, and revenue of $18.94M, 3.46% above expectations.
The stock price moved up 1.03%, changed from $13.56 before the earnings release to $13.70 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on 7 analysts, Carlsmed, Inc. Common Stock is expected to report EPS of -$0.41 and revenue of $19.32M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement